Antitumor Agents from Higher Plants

  • Richard G. Powell
  • Cecil R. SmithJr.
Part of the Recent Advances in Phytochemistry book series (RAPT, volume 14)


Various plant preparations have been recommended for treatment of warts, tumors and cancerous growths throughout recorded history. In a classic survey of the available literature, Hartwell1 identified over 3,000 plants reported to be of use in the treatment of these maladies. Numerous plant extracts have been subjected to detailed testing and fractionation studies in recent years and a wide variety of new active compounds have been isolated. Many of these new materials show promising antitumor activity in animal test systems and in preliminary clinical trials.


Antitumor Activity Tumor Inhibitor Seed Extract Antitumor Agent Sesquiterpene Lactone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hartwell, J.L. 1967. Plants used against cancer. A survey. Lloydia 30: 379 (with ten additional installments ending with Lloydia 34: 386 ).Google Scholar
  2. 2.
    Carter, S.K. and R.B. Livingston. 1976.. Plant products in cancer chemotherapy. Cancer Treat. Rep. 60: 1141.PubMedGoogle Scholar
  3. 3.
    Schepartz, S.A. 1976. History of the National Cancer Institute and the Plant Screening Program. Cancer Treat. Rep. 60: 975.PubMedGoogle Scholar
  4. 4.
    Perdue, R.E., Jr. 1976. Procurement of plant materials for antitumor screening. Cancer Treat. Rep. 60: 987.PubMedGoogle Scholar
  5. 5.
    Abbott, B.J. 1976. Bioassay of plant extracts for anticancer activity. Cancer Treat. Rep. 60: 1007.PubMedGoogle Scholar
  6. 6.
    Geran, R.I., N.H. Greenberg, M.M. MacDonald, A.M. Schumacher and B.J. Abbott. 1972. Protocols for screening chemical agents and natural products against animal tumors and other biological systems (Third Edition). Cancer Chemother. Rep. Part 3, 3: 1.Google Scholar
  7. 7.
    Hartwell, J.L. and B.J. Abbott. 1969. Antineoplastic principles in plants: recent developments in the field. Adv. Pharmacol. Chemother. 7: 117.PubMedCrossRefGoogle Scholar
  8. 8.
    Kupchan, S.M. 1975. Advances in the chemistry of tumor-inhibitory natural products. Rec. Adv. Phytochem. 9: 167.CrossRefGoogle Scholar
  9. 9.
    Hartwell, J.L. 1976. Types of anticancer agents isolated from plants. Cancer Treat. Rep. 60: 1031.PubMedGoogle Scholar
  10. 10.
    Wall, M.E. and M.C. Wani. 1977. Antineoplastic agents from plants. Annu. Rev. Pharmacol. Toxicol. 17: 117.PubMedCrossRefGoogle Scholar
  11. 11.
    Cordell, G.A. 1979. Anticancer agents from plants. Prog. Phytochem. 5: 273.Google Scholar
  12. 12.
    Pettit, G.R. 1977. Biosynthetic products for cancer therapy. 1: 228 pp.Google Scholar
  13. 13.
    Tornita, M., H. Furukawa, S.T. Lu and S.M. Kupchan. 1965. The constitution of thalicarpine. Tetrahedron Lett. 4309.Google Scholar
  14. 14.
    Kupchan, S.M., N. Yokoyama and B.S. Thyagarajan. 1961. Menispermaceae alkaloids. H. The alkaloids of Cyclea peltata Diels. J. Pharm. Sci. 50: 164.PubMedCrossRefGoogle Scholar
  15. 15.
    Kupchan, S.M. and A.J. Liepa. 1971. Total synethesis of the tumor-inhibitory alkaloids thalicarpine and hernandaline. Chem. Commun. 599.Google Scholar
  16. 16.
    Gilmore, C.J., R.F. Bryan and S.M. Kupchan. 1976. Conformation and reactivity of the macrocyclic tumor-inhibitory alkaloid tetrandrine. J. Am. Chem. Soc. 98: 1947.PubMedCrossRefGoogle Scholar
  17. 17.
    Sieber, S.M., J.A.R. Mead and R.H. Adamson. 1976. Pharmacology of antitumor agents from higher plants. Cancer Treat. Rep. 60: 1127.PubMedGoogle Scholar
  18. 18.
    Herman, E.H. and D.P. Chadwick. 1974. Cardiovascular effects of d-tetrandrine. Pharmacology 12: 97.PubMedCrossRefGoogle Scholar
  19. 19.
    Panettiere, F. and C.A. Coltman, Jr. 1971. Phase I experience with emetine hydrochloride (NSC 33669) as an antitumor agent. Cancer 27: 835.PubMedCrossRefGoogle Scholar
  20. 20.
    Siddiqui, S., D. Firat and S. Olshin. 1973. Phase II study of emetine (NSC 33669) in the treatment of solid tumors. Cancer Chemother. Rep. Part I, 57: 423.Google Scholar
  21. 21.
    Wall, M.E., M.C. Wani, C.E. Cook, K.N. Palmer, A.T. McPhail and G.A. Sim. 1966. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J. Am. Chem. Soc. 88: 3888.CrossRefGoogle Scholar
  22. 22.
    Wani, M.C. and M.E. Wall. 1969. Plant antitumor agents. II. The structure of two new alkaloids from Camptotheca acuminata. J. Org. Chem. 34: 1364.CrossRefGoogle Scholar
  23. 23.
    Moertel, C.G., A.J. Schutt, R.J. Reitemeier and R.G. Hahn. 1972. Phase II study of camptothecin (NSC 100880) in the treatment of advanced gastrointestinal cancer. Cancer Chemother. Rep. Part I, 56: 95.Google Scholar
  24. 24.
    Gottlieb, J.A. and J.K. Luce. 1972. Treatment of malignant melanoma with camptothecin (NSC 100880). Cancer Chemother. Rep. Part 1, 56: 103.Google Scholar
  25. 25.
    Schaeppi, U., R.W. Fleischman and D.A. Cooney. 1974. Toxicity of camptothecin (NSC 100880). Cancer Chemother. Rep. Part 3, 5: 25.Google Scholar
  26. 26.
    Agarwal, J.S. and R.P. Rastogi. 1973. Chemical constituents of Mappia foetida Miers. Indian J. Chem. 11: 969.Google Scholar
  27. 27.
    Tafur, S., J.D. Nelson, D.C. DeLong and G.H. Svoboda. 1976. Antiviral components of Ophiorrhiza mungos. Isolation of camptothecin and 10-methoxycamptothecin. Lloydia 39: 261.Google Scholar
  28. 28.
    Winterfeldt, E. 1975. Recent Dev. Chem. Nat. Carbon Compd. 6: 9.Google Scholar
  29. 29.
    Shamma, M. and V. St. Georgiev. 1974. Camptothecin. J. Pharm. Sci. 63: 163.PubMedCrossRefGoogle Scholar
  30. 30.
    Schultz, A.G. 1973. Camptothecin. Chem. Rev. 73: 385.PubMedCrossRefGoogle Scholar
  31. 31.
    Svoboda, G.H., G.A. Poore and M.L. Montfort. 1968. Alkaloids of Ochrosia maculata Jacq. (Ochrosia borbonica Gmel.). J. Pharm. Sci. 57: 1720.PubMedCrossRefGoogle Scholar
  32. 32.
    Hayat, M., G. Mathé, M.M. Janot, P. Potier, N. Dat-Xuong, A. Cavé, T. Sevenet, C. Kan-Fan, J. Poisson, J. Miet, J. Le Men, F. LeGoffic, A. Gouyette, A. Ahond, L.K. Dalton and T.A. Connors. 1974. Experimental screening of 3 forms and 19 derivatives or analogs of ellipticine: oncostatic effect on L1210 leukemia and immunosuppressive effect of 4 of them. Biomedicine 21: 101.PubMedGoogle Scholar
  33. 33.
    Herman, E.H., D.P. Chadwick and R.M. Mhatre. 1974. Comparison of the acute hemolytic and cardiovascular actions of ellipticine (NSC 71795) and some ellipticine analogs. Cancer Chemother. Rep. Part 1, 58: 637.Google Scholar
  34. 34.
    Svoboda, G.H., G.H. Poore, P.J. Simpson and G.B. Boder. 1966. Alkaloids of Acronychia baueri Schott. I. Isolation of the alkaloids and a study of the antitumor and other biological properties of acronycine. J. Pharm. Sci. 55: 758.PubMedCrossRefGoogle Scholar
  35. 35.
    Svoboda, G.H. 1966. Alkaloids of Acronychia baueri (Bauerella australiana). II. Extraction of the alkaloids and studies of structure-activity relationships. Lloydia 29: 206.Google Scholar
  36. 36.
    Schneider, J., E.L. Evans, E. Grunberg and R.I. Fryer. 1972. Synthesis and biological activity of acronycine analogs. J. Med. Chem. 15: 266.PubMedCrossRefGoogle Scholar
  37. 37.
    Beck, J.R., R. Kwok, R.N. Booher, A.C. Brown, L.E. Patterson, P. Pranc, B. Rockey and A. Pohland. 1968. Synthesis of acronycine. J. Am. Chem. Soc. 90: 4706.PubMedCrossRefGoogle Scholar
  38. 38.
    Mulchandani, N.B. and S.R. Venkatachalam. 1976. Alkaloids of Pergularia pallida. Phytochemistry 15: 1561.CrossRefGoogle Scholar
  39. 39.
    Gellert, E., T.R. Govindachari, M.V. Lakshmikantham, I.S. Ragade, R. Rudzats and N. Viswanathan. 1962. The alkaloids of Tylophora crebriflora: structure and synthesis of tylocrebrine, a new phenanthroindolizidine alkaloid. J. Chem. Soc. 1008.Google Scholar
  40. 40.
    Farnsworth, N.R., A.S. Bingel, H.H.S. Fong, A.A. Saleh, G.M. Christenson and S.M. Sauffer. 1976. Oncogenic and tumor-promoting spermatophytes and pteridophytes and their active principles. Cancer Treat.Rep.60: 1171.Google Scholar
  41. 41.
    Kupchan, S.M., R.W. Doskotch and P.W. Vanevenhoven. 1964. Tumor inhibitors. III. Monocrotaline, the active principle of Crotalaria spectabilis. J. Pharm. Sci. 53: 343.Google Scholar
  42. 42.
    Kugelman, M., W. Liu, M. Axelrod, T.J. McBride and K.V. Rao. 1976. Indicine-N-Oxide: the antitumor principle of Heliotropium indicum. Lloydia 39: 125.Google Scholar
  43. 43.
    Kupchan, S.M., Y. Aynehchi, J.M. Cassady, H.K. Schnoes and A.L. Burlingame. 1969. Tumor inhibitors. XL. The isolation and structural elucidation of elephantin and elephantopin, two novel sesquiterpenoid tumor inhibitors from Elephantopus elatus. J. Org. Chem. 34: 3867.CrossRefGoogle Scholar
  44. 44.
    Kupchan, S.M., R.J. Hemingway, D. Werner and A. Karim. 1969. Tumor Inhibitors. XLVI. Vernolepin, a novel sesquiterpene dilactone tumor inhibitor from Vernonia hymenolepis A. Rich. J. Org. Chem. 34: 3903.Google Scholar
  45. 45.
    Kupchan, S.M., M.A. Eakin and A.M. Thomas. 1971. Tumor inhibitors. 69. Structure-cytotoxicity relationships among the sesquiterpene lactones. J. Med. Chem. 14: 1147.PubMedCrossRefGoogle Scholar
  46. 46.
    Rodriguez, E., G.H.N. Towers and J.C. Mitchell. 1976. Biological activities of sesquiterpene lactones. Phytochemistry 15: 1573.CrossRefGoogle Scholar
  47. 47.
    Mitchel, J.C. 1975. Contact allergy from plants. Recent Adv. Phytochem. 9: 119.CrossRefGoogle Scholar
  48. 48.
    Block, J.B., A.A. Serpick, W. Miller and P.H. Wiernik. 1974. Early clinical studies with lapachol (MSC 11905). Cancer Chemother. Rep. Part 2, 4: 27.Google Scholar
  49. 49.
    Rao, K.V. 1974. Quinone natural products: streptonigrin (NSC 45383) and lapachol (NSC 11905) structure-activity relationships. Cancer Chemother. Rep. Part 2, 4: 11.Google Scholar
  50. 50.
    Messmer, W.M., M. Tin-Wa, H.H.S. Fong,,,C. Bevelle, N.R. Farnsworth, D.J. Abraham and J. Trojanek. 1972. Fagaronine, a new tumor inhibitor isolated from Fagara zanthoxyloides Lam. (Rutaceae). J. Pharm. Sci. 61: 1858.PubMedGoogle Scholar
  51. 51.
    Arthur, H.R., W.H. Hui and Y.L. Ng. 1959. An examination of the rutaceae of Hong Kong. Part II. The alkaloids, nitidine and oxynitidine, from Zanthoxylum nitidum. J. Chem. Soc. 1840.Google Scholar
  52. 52.
    Gillespie, J.P., L.G. Amoros and F.R. Stermitz. 1974. Synthesis of fagaronine. An anticancer benzophenanthridine alkaloid. J. Org. Chem. 39: 3239.CrossRefGoogle Scholar
  53. 53.
    Ninomiya, I., T. Naito and H. Ishii. 1975. Synthesis of N-demethylfagaronine. Heterocycles 3: 307.CrossRefGoogle Scholar
  54. 54.
    Stermitz, F.R., K.A. Larson and D.K. Kim. 1973. Some structural relationships among cytotoxic and antitumor benzophenanthridine alkaloid derivatives. J. Med. Chem. 16: 939.PubMedCrossRefGoogle Scholar
  55. 55.
    Powell, R.G., D. Weisleder and C.R. Smith, Jr. 1972. Antitumor alkaloids from Cephalotaxus harringtonia: structure and activity. J. Pharm. Sci. 61: 1227.PubMedCrossRefGoogle Scholar
  56. 56.
    Corbett, T.H., D.P. Griswold, Jr., B.J. Roberts, J.C. Peckham and F.M. Schable, Jr. 1977. Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas. Cancer 40: 2660.PubMedCrossRefGoogle Scholar
  57. 57.
    Weinreb, S.M. and J. Auerbach. 1975. Total synthesis of the Cephalotaxus alkaloids. Cephalotaxine, cephalotaxinone and demethylcephalotaxinone. J. Am. Chem. Soc. 97: 2503.CrossRefGoogle Scholar
  58. 58.
    Semmelhack, M.F., B.P. Chong, R.D. Stauffer, T.D. Rogerson, A. Chong and L.D. Jones. 1975. Total synthesis of the Cephalotaxus alkaloids. A problem in nucleophilic aromatic substitution. J. Am. Chem. Soc. 97: 2507.PubMedCrossRefGoogle Scholar
  59. 59.
    Mikolajczak, K.L., C.R. Smith, Jr., D. Weisleder, T.R. Kelly, J.C. McKenna and P.A. Christenson. 1974. Synthesis of deoxyharringtonine. Tetrahedron Lett. 283.Google Scholar
  60. 60.
    Anon. 1975. Partial synthesis of harringtonine. ‘Co Hsueh T’ung Pao 20: 437.Google Scholar
  61. 61.
    Mikolajczak, K.L. and C.R. Smith, Jr. 1978. Synthesis of harringtonine, a Cephalotaxus antitumor alkaloid. J. Org. Chem. 43: 4762.CrossRefGoogle Scholar
  62. 62.
    Kelly, T.R., R.W. McNutt, M. Montury, N.P. Tosches, K.L. Mikolajczak, C.R. Smith, Jr. and D. Weisleder. 1979. Preparation of harringtonine from cephalotaxine. J. Org. Chem. 44: 63.CrossRefGoogle Scholar
  63. 63.
    Mikolajczak, K.L. and C.R. Smith, Jr. 1979. Synthetic cephalotaxine esters having antileukemic activity. U.S. Patent 4,152, 333.Google Scholar
  64. 64.
    Smith, C.R., Jr., K.L. Mikolajczak and R.G. Powell. Harringtonine and related cephalotaxine esters. In Design and Synthesis of Potential Anti-Cancer Agénts Based on Natural Product Models (J.M. Cassady and J.D. Douros, eds). In press.Google Scholar
  65. 65.
    Anon. 1976. Cephalotaxine esters in the treatment of acute leukemia, a preliminary clinical assessment. Chin. Med. J. (Peking Engl. Ed.) 2: 263.Google Scholar
  66. 66.
    Anon. 1977. Harringtonine in acute leukemias, clinical analysis of 31 cases. Chin. Med. J. (Peking Engl. Ed.) 3: 319.Google Scholar
  67. 67.
    Wani, M.C., H.L. Taylor, M.E. Wall, P. Coggon and A.T. McPhail. 1971. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93: 2325.CrossRefGoogle Scholar
  68. 68.
    Powell, R.G., R.W. Miller and C.R. Smith, Jr. 1979. Cephalomannine; a new antitumor alkaloid from Cephalotaxus mannii. Chem. Commun. 102.Google Scholar
  69. 69.
    Polonsky, J. 1973. Quassinoid bitter principles. Prog. Chem. Org. Nat. Prod. 30: 101.Google Scholar
  70. 70.
    Kupchan, S.M., R.W. Britton, J.A. Lacadie, M.F. Ziegler and C.W. Sigel. 1975. The isolation and structural elucidation of bruceantin and bruceantinol, new potent antileukemic quassinoids from Brucea antidysenterica. J. Org. Chem. 40: 648.CrossRefGoogle Scholar
  71. 71.
    Ogura, M., G.A. Cordell, A.D. Kinghorn and N.R. Farnsworth. 1977. Potential anticancer agents. VI. Constituents of Ailanthus excelsa (Simaroubaceae). Lloydia 40: 579.PubMedGoogle Scholar
  72. 72.
    Wani, M.C., H.L. Taylor, J.B. Thompson and M.E. Wall. 1978. Plant antitumor agents. XVI. 6a-Senecioyloxychaparrinone, a new antileukemic quassinoid from Simaba multiflora. Lloydia 41: 578.Google Scholar
  73. 73.
    Wall, M.E. and M.C. Wani. 1978. Plant antitumor agents. 17. Structural requirements for antineoplastic activity in quassinoids. J. Med. Chem. 21: 1186.PubMedCrossRefGoogle Scholar
  74. 74.
    Evans, F.J. and C.J. Soper. 1978. The tigliane, daphnane and ingenane diterpenes, their chemistry, distribution and biological activities. A review. Lloydia 41: 193.Google Scholar
  75. 75.
    Kupchan, S.M., J.G. Sweeny, R.L. Baxter, T. Murae, V.A. Zimmerly and B.R. Sickles. 1975. Gnididin, gniditrin and gnidicin, novel potent antileukemic diterpenoid esters from Gnidia lamprantha. J. Am. Chem. Soc. 97: 672CrossRefGoogle Scholar
  76. 76.
    Kupchan, S.M., Y. Shizuri, T. Murae, J.G. Sweeny, H.R. Haynes, M.S. Shen, J.C. Barrick, R.F. Bryan, D. van der Helm and K.K. Wu. 1976. Gnidimacrin and gnidimacrin 20-palmitate, novel macrocyclic antileukemic diterpenoid esters from Gnidia subcordata. J. Am. Chem. Soc. 98: 5719.CrossRefGoogle Scholar
  77. 77.
    Kupchan, S.M. and R.L. Baxter. 1975. Mezerein: anti-leukemic principle isolated from Daphne mezereum L. Science 187: 652.Google Scholar
  78. 78.
    Kupchan, S.M., Y. Komoda, W.A. Court, G.J. Thomas, R.M. Smith, A. Karim, C.J. Gilmore, R.C. Haltiwanger and R.F. Bryan. 1972. Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus. J. Am. Chem. Soc. 95: 1354.CrossRefGoogle Scholar
  79. 79.
    Wani, M.C., H.L. Taylor and M.E. Wall. 1973. Plant antitumor agents: colubrinol acetate and colubrinol, antileukaemic ansa macrolides from Colubrina texensis. Chem. Commun. 390.Google Scholar
  80. 80.
    Kupchan, S.M., Y. Komoda, A.R. Branfman, A.T. Sneden, W.A. Court, G.J. Thomas, N.P.J. Hintz, R.M. Smith, A. Karim, G.A. Howie, A.K. Verma, Y. Nagao, R.G. Dailey, Jr., V.A. Zimmerly and W.C. Sumner, Jr. 1977. The maytansinoids. Isolation, structural elucidation and chemical interrelation of novel ansa macrolides. J. Org. Chem. 42: 2349.CrossRefGoogle Scholar
  81. 81.
    Kupchan, S.M., A.T. Sneden, A.R. Branfman, G.A. Howie, L.I. Rebhun, W.E. Mclvor, R.W. Wang and T.C. Schnaitman. 1978. Structural requirements for anti-leukemic activity among the naturally occurring and semisynthetic maytansinoids. J. Med. Chem. 21: 31.PubMedCrossRefGoogle Scholar
  82. 82.
    Chabner, B.A., A.S. Levine, B.L. Johnson and R.C. Young. 1978. Initial clinical trials of maytansine, an antitumor plant alkaloid. Cancer Treat. Rep. 62: 429.PubMedGoogle Scholar
  83. 83.
    Kingsbury, J.M. 1964. Poisonous Plants of the United States and Canada, Prentice-Hall, pp. 353–357.Google Scholar
  84. 84.
    Powell, R.G., C.R. Smith, Jr. and R.V. Madrigal. 1976. Antitumor activity of Sesbania vesicaria, S. punicea and S. drummondii seed extracts. Planta Méd. 30: 1.PubMedCrossRefGoogle Scholar
  85. 85.
    Powell, R.G., C.R. Smith, Jr., D. Weisleder, D.A. Muthard and J. Clardy. 1979. Sesbanine, a novel cytotoxic alkaloid from Sesbania drummondii. J. Am. Chem. Soc. 101: 2784.CrossRefGoogle Scholar
  86. 86.
    Kupchan, S.M., W.A. Court, R.G. Dailey, Jr., C.J. Gilmore and R.F. Bryan. 1972. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. J. Am. Chem. Soc. 94: 7194.CrossRefGoogle Scholar
  87. 87.
    Kupchan, S.M., D.R. Streelman, B.B. Jarvis, R.G. Dailey, Jr. and A.T. Sneden. 1977. Isolation of potent new antileukemic trichothecenes from Baccharis megapotamica. J. Org. Chem. 42: 4221.CrossRefGoogle Scholar
  88. 88.
    Douros, J. and M. Suffness. 1978. New natural products of interest under development at the National Cancer Institute. Cancer Chemother. Pharmacol. 1: 91.PubMedCrossRefGoogle Scholar
  89. 89.
    Jolad, S.D., R.M. Wiedhopf and J.R. Cole. 1975. Tumor-inhibitory agent from Montezuma speciosissima (Malvaceae). J. Pharm. Sci. 64: 1889.PubMedCrossRefGoogle Scholar
  90. 90.
    Anon. February 19, 1979. Chem. Eng. News., p. 33.Google Scholar
  91. 91.
    Spencer, G.F., R.D. Plattner and R.G. Powell. 1976. Quantitative gas chromatography and gas chromatography-mass spectrometry of Cephalotaxus alkaloids. J. Chromatogr. 120: 335.PubMedCrossRefGoogle Scholar
  92. 92.
    Kupchan, S.M., C.W. Sigel, L.J. Guttman, R.J. Restivo and R.F. Bryan. 1972. Datiscoside, a novel anti-leukemic cucurbitacin glycoside from Datisca glomerata. J. Am. Chem. Soc. 94: 1353.CrossRefGoogle Scholar
  93. 93.
    Ogura, M., K. Koike, G.A. Cordell and N.R. Farnsworth. 1978. Potential anticancer agents. VIII. Constituents of Baliospermum montanum (Euphorbiaceae). Planta Med. 33: 128.PubMedCrossRefGoogle Scholar
  94. 94.
    Loder, J.W. and R.H. Nearn. 1975. 30-Acetoxynorerythrosuamine, a highly cytotoxic alkaloid from Erythrophleum. Tetrahedron Lett. 2497.Google Scholar
  95. 95.
    Warthen, D., E.L. Gooden and M. Jacobson. 1969. Tumor inhibitors: liriodenine, a cytotoxic alkaloid from Annona glabra. J. Pharm. Sci. 58: 637.CrossRefGoogle Scholar
  96. 96.
    Galsky, A.G., J.P. Wilsey and R.G. Powell. 1980. Crown-gall tumor disc bioassay: a possible aid in the detection of compounds with antitumor activity. Plant Physiol. 65: 184.PubMedCrossRefGoogle Scholar
  97. 97.
    Glogowski, W. and A.G. Galsky. 1978. Agrobacterium tumefaciens site attachment as a necessary prerequisite for crown gall tumor formation on potato discs. Plant Physiol. 61: 1031.PubMedCrossRefGoogle Scholar
  98. 98.
    Richardson, C.L. and D.J. Morre. 1978. Chemotherapy of plant tumors: regression of crown gall tumors with D-glucosamine. Bot. Gaz. 139: 196.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • Richard G. Powell
    • 1
  • Cecil R. SmithJr.
    • 1
  1. 1.Northern Regional Research Center, Agricultural Research, Science and Education AdministrationU.S. Department of AgriculturePeoriaUSA

Personalised recommendations